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The mycotoxin phomoxanthone A disturbs
the form and function of the inner
mitochondrial membrane
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Jana Deitersen1, Nora Wallot-Hieke1, Wenxian Wu1, Marian Frank3, Hendrik Niemann3, Elisabeth Wesbuer4,
Andreas Barbian4, Tomas Luyten5, Jan B. Parys 5, Stefanie Weidtkamp-Peters6, Andrea Borchardt2,
Andreas S. Reichert2, Aida Peña-Blanco7, Ana J. García-Sáez7, Samuel Itskanov8, Alexander M. van der Bliek8,
Peter Proksch3, Sebastian Wesselborg1 and Björn Stork 1
Abstract
Mitochondria are cellular organelles with crucial functions in the generation and distribution of ATP, the buffering of
cytosolic Ca2+ and the initiation of apoptosis. Compounds that interfere with these functions are termed
mitochondrial toxins, many of which are derived from microbes, such as antimycin A, oligomycin A, and ionomycin.
Here, we identify the mycotoxin phomoxanthone A (PXA), derived from the endophytic fungus Phomopsis longicolla,
as a mitochondrial toxin. We show that PXA elicits a strong release of Ca2+ from the mitochondria but not from the ER.
In addition, PXA depolarises the mitochondria similarly to protonophoric uncouplers such as CCCP, yet unlike these, it
does not increase but rather inhibits cellular respiration and electron transport chain activity. The respiration-
dependent mitochondrial network structure rapidly collapses into fragments upon PXA treatment. Surprisingly, this
fragmentation is independent from the canonical mitochondrial fission and fusion mediators DRP1 and OPA1, and
exclusively affects the inner mitochondrial membrane, leading to cristae disruption, release of pro-apoptotic proteins,
and apoptosis. Taken together, our results suggest that PXA is a mitochondrial toxin with a novel mode of action that
might prove a useful tool for the study of mitochondrial ion homoeostasis and membrane dynamics.
Introduction
Mitochondria are cellular organelles that are crucial to
almost all eukaryotic organisms. Among their most
important functions are generation and distribution of
ATP, buffering of cytosolic Ca2+ and, in animal cells,
initiation of apoptosis. Disturbance of these or other
functions by mitochondrial toxins can lead to cellular
stress and cell death1,2.
Mitochondria produce ATP through oxidative phos-
phorylation (OXPHOS), which depends on the electron
transport chain (ETC) embedded in the inner mitochon-
drial membrane (IMM). The ETC pumps protons out of
the mitochondrial matrix and into the mitochondrial
intermembrane space. This generates a proton gradient
(ΔpHm) and, consequently, a membrane potential (ΔΨm)
across the IMM. The ΔΨm is then used to drive the
mitochondrial ATP synthase3.
To provide all regions within the cell with sufficient
ATP, mitochondria often form a network that constantly
undergoes balanced fission and fusion. This allows
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remodelling of the network as well as removal and recy-
cling of damaged mitochondria through mitophagy1,4,5.
Excessive fission can be triggered by mitochondrial toxins
that cause loss of ΔΨm, such as the protonophore car-
bonyl cyanide m-chlorophenyl hydrazone (CCCP)6.
The ΔΨm also plays a role in the mitochondrial buf-
fering of cytosolic Ca2+. Normally, the cytosol of a typical
animal cell contains only a very low Ca2+ concentration
([Ca2+]cyt, ~0.1 µM), whereas the concentration of Ca
2+
within the endoplasmic reticulum ([Ca2+]ER,> 100 µM) or
outside the cell ([Ca2+]ext,> 1000 µM) is up to 10,000-fold
higher2. In response to certain stimuli, Ca2+ channels in
the ER and/or the plasma membrane open to release Ca2+
into the cytosol as a second messenger. Mitochondria
contribute to removal of cytosolic Ca2+ by uptake into
their matrix via ΔΨm-driven Ca2+ transporters. After that,
a slow, regulated efflux moves the Ca2+ out of the matrix
and into the cristae, which are folds in the IMM, from
where it is slowly released and shuttled back to the ER2,7–
9. A separate mechanism through which Ca2+ can cross
the IMM is the mitochondrial permeability transition
pore (mPTP), which can open irreversibly in response to
severe mitochondrial stress. The mPTP directly connects
the mitochondrial matrix with the cytosol to allow the
free exchange of molecules up to 1.5 kDa in size, including
Ca2+. Irreversible mPTP opening leads to release of
mitochondrial Ca2+, loss of ΔΨm, swelling of the matrix
and eventually mitochondrial outer membrane permea-
bilisation (MOMP)10,11.
In animal cells, MOMP initiates apoptosis. Several
proteins normally contained in the cristae attain a pro-
apoptotic function if they pass the outer mitochondrial
membrane (OMM) and are released into the cytosol.
Among these proteins are cytochrome c (CYCS), SMAC
(DIABLO) and OMI (HTRA2). Cytosolic CYCS becomes
part of the caspase-activating apoptosome complex, while
DIABLO and HTRA2 bind and inhibit the inhibitor of
apoptosis proteins (IAPs), thus attenuating their inhibi-
tion of caspases1. MOMP can be caused either passively
through rupture of the OMM, such as triggered by the
mPTP, or actively through the formation of pores in the
OMM by the pro-apoptotic proteins BAK and BAX,
which can be induced in response to severe cellular
stress12.
A variety of mitochondrial toxins with different effects
and molecular targets is known today13. Several of these
toxins are natural products, such as the Streptomyces-
derived ETC inhibitor antimycin A and the ATP synthase
inhibitor oligomycin A.
Phomoxanthone A and B (PXA and PXB) are natural
products named after the fungus Phomopsis, from which
they were first isolated, and after their xanthonoid
structure (Fig. S1). PXA is a homodimer of two acetylated
tetrahydroxanthones symmetrically linked at C-4,4’,
whereas PXB is structurally almost identical but asym-
metrically linked at C-2,4’. Both possess antibiotic activity
against diverse organisms from all biological kingdoms.
Originally described in 2001, PXA and PXB were tested
against the protozoan Plasmodium falciparum, the Gram-
positive Mycobacterium tuberculosis, and three animal
cell lines. In all of these organisms, both PXA and PXB
showed significant cytotoxic activity, with PXA being
more toxic in every case14. A later study in different
organisms produced similar results, showing that PXA
inhibits the growth of the Gram-positive Bacillus mega-
terium, the alga Chlorella fusca, and the fungus Ustilago
violacea15.
We previously showed that PXA induces apoptosis in
human cancer cell lines. Signs of apoptosis were observed
as early as after 4 h of treatment with low micromolar
doses of PXA16,17. However, the mechanism by which
PXA causes apoptosis or cytotoxicity in general has never
before been investigated.
The aim of this study was to elucidate the mechanism
through which PXA exerts its toxicity. Following our
initial results, we hypothesised that PXA directly affects
the mitochondria and thus investigated its effects on the
ETC, ΔΨm, ATP production, Ca2+ buffering, and
mitochondrial morphology. It appears that PXA is a
mitochondrial toxin that specifically affects the IMM,
leading to loss of ΔΨm, ETC inhibition, Ca2+ efflux,
mitochondrial fragmentation, cristae disruption, and
finally to the release of mitochondrial pro-apoptotic
factors.
Results
PXA induces Ca2+ release from an intracellular store
To determine how PXA induces apoptosis, we analysed
its effect on cellular Ca2+ levels since ionic imbalance
can be an apoptotic trigger. Treatment of Ramos cells
with PXA resulted in a strong, steady increase of [Ca2
+]cyt (Fig. 1a). Interestingly, there was a delay of about
2–5 min between addition of PXA and increase in [Ca2
+]cyt. Since this pattern of Ca
2+ release is similar to that
caused by the tyrosine phosphatase inhibitor pervana-
date (VO4
3−) (Fig. S2a), and since tyrosine phosphatase
inhibition can induce apoptosis, we tested the effect of
PXA on tyrosine phosphorylation. However, in contrast
to pervanadate, we could not detect any effect (Fig. S2b).
In a broader picture, PXA had no inhibitory effect on any
of 141 protein kinases against which we tested it
(Table S1).
We next tried to determine the origin of the released
Ca2+. Since PXA increases [Ca2+]cyt even in the absence
of extracellular Ca2+, we tested if it releases Ca2+ from the
ER. Using thapsigargin, which causes a net efflux of Ca2+
from the ER, we could induce an increase in [Ca2+]cyt
even after PXA-inducible Ca2+ stores were depleted
Böhler et al. Cell Death and Disease  (2018) 9:286 Page 2 of 17
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(Fig. 1b), suggesting that the Ca2+ released by PXA at
least partially originates from a source other than the ER.
PXA induces Ca2+ release mainly from the mitochondria
To quantify the effect of PXA on Ca2+ stores, we used
HeLa cells expressing CEPIA Ca2+ probes targeted to
either the ER or the mitochondria. Although PXA pro-
voked some Ca2+ release from the ER, it was much slower
and weaker than that evoked by thapsigargin (Fig. 1c).
Mitochondria, however, were quickly and severely
depleted (Fig. 1d). This effect of PXA on mitochondrial
Ca2+ was confirmed in Ramos cells, making use of the Ca2
+ probe Pericam (Fig. 1e).
Mitochondrial Ca2+ release caused by PXA is independent
from the mPTP
Large-scale Ca2+ efflux from the mitochondria can
result from persistent opening of the mPTP. We thus
tested whether PXA induces mPTP opening by using the
cobalt/calcein method, comparing PXA to the mPTP
inducer ionomycin (IM). While IM caused a strong
decrease in mitochondrial calcein fluorescence as expec-
ted, PXA had no observable effect (Fig. 1f, g; Supple-
mentary Movies S1–S3). Similar results were obtained by
further live measurement using flow cytometry (Fig. 1h).
In addition, we tested whether the mPTP inhibitor
cyclosporin A (CsA) can prevent the mitochondrial Ca2+
release caused by PXA. We measured mitochondrial Ca2+
retention capacity in isolated mitochondria, comparing
PXA to IM and CCCP. This was done in either normal
isolated mitochondria or mitochondria loaded with Ca2+,
and in the presence of either CsA or its derivative
cyclosporin H (CsH), which does not affect the mPTP
(Fig. 2)18. While PXA caused a decrease in calcium green
fluorescence, indicating Ca2+ release, under every condi-
tion, i.e., regardless of Ca2+ loading and also in the pre-
sence of CsA, IM had an observable effect only in loaded
mitochondria, but also regardless of CsA. On the other
hand, CCCP caused a release of Ca2+ only in the presence
of CsH but not CsA, indicating that CCCP-induced Ca2+
release does indeed depend on the mPTP, unlike that
induced by PXA. Taken together, these results indicate
that PXA causes mitochondrial Ca2+ release largely
independent from the mPTP.
PXA depolarises the mitochondria but does not uncouple
cellular respiration
A change in [Ca2+]mito likely correlates with changes in
other mitochondrial ion gradients. Uptake of Ca2+ into
the mitochondrial matrix is driven by ΔΨm. We thus
analysed the effect of PXA on ΔΨm. Indeed, PXA caused
immediate mitochondrial depolarisation similar to CCCP,
both in whole cells and isolated mitochondria (Fig. 3a, b).
The EC50 for PXA-induced loss of ΔΨm in Ramos cells
was determined to be 1.1± 0.3 µM (Fig. S3). The key
contributor to ΔΨm is ΔpHm, which is maintained via
cellular respiration by consumption of O2. If the PXA-
induced loss of ΔΨm was caused by loss of ΔpHm
downstream of the ETC, as in case of CCCP, it would be
accompanied by an increase in respiration to compensate
for the loss. Therefore, we measured cellular O2 con-
sumption upon increasing concentrations of either PXA
or CCCP. As expected, CCCP caused a dose-dependent
increase in O2 consumption. However, in contrast to
CCCP, PXA caused no increase but rather a slight
decrease in O2 consumption (Fig. 3c). An overview of the
kinetics of the effects of PXA on [Ca2+]cyt, [Ca
2+]mito, O2
consumption and ΔΨm is presented in Fig. 3d.
PXA inhibits cellular respiration by disrupting the electron
transport chain
Since PXA had a moderate inhibitory effect on cellular
O2 consumption under basal conditions, we next mea-
sured O2 consumption after the respiration rate was first
increased by CCCP. Here, treatment with PXA caused a
strong decrease in O2 consumption to levels below
baseline (Fig. 4a). It thus appeared likely that PXA, unlike
CCCP, is not an inducer but rather an inhibitor of cellular
respiration and of the ETC. We, therefore, compared PXA
to known ETC inhibitors: rotenone (complex I), the-
noyltrifluoroacetone (TTFA; complex II), antimycin A
(complex III), sodium azide (NaN3; complex IV) and
Fig. 1 PXA causes an increase of [Ca2+]cyt and a release of [Ca
2+]mito but not [Ca
2+]ER. a Live measurement of the effect of PXA (10 µM) on [Ca
2
+]cyt in Ramos cells, where DMSO (0.1% v/v) was used as vehicle control and ionomycin (IM; 2 µM) was used as positive control, and b live
measurement of [Ca2+]cyt after PXA followed by thapsigargin (TG; 10 µM). Measurements were performed by flow cytometry using the Ca
2+-sensitive
fluorescent probe Fluo-4-AM (Ex 488 nm, Em 530 ± 30 nm) in the absence of extracellular Ca2+ by maintaining the cells in Krebs-Ringer buffer
containing 0.5 mM EGTA during measurement. c, d Comparison of the effect of PXA (10 µM) and thapsigargin (TG; 1 µM) on either [Ca2+]ER or
[Ca2+]mito as measured by the Ca
2+-sensitive fluorescent protein CEPIA targeted to the respective organelle in HeLa cells. All traces were normalised
(F/F0) where F0 is the starting fluorescence of each trace. e Comparison of the effect of PXA (10 µM), ionomycin (IM; 2 µM), and thapsigargin (TG; 1
µM) on [Ca2+]mito in Ramos cells stably transfected with the Ca
2+-sensitive ratiometric fluorescent protein mito-Pericam. DMSO (0.1% v/v) was used as
vehicle control. F/F0 is the ratio of fluorescence with excitation at 488 nm (high [Ca
2+]) to 405 nm (low Ca2+]). f, g Live imaging and quantification of
the effect of PXA (10 µM) on mPTP opening in HeLa cells as measured by mitochondrial calcein fluorescence using the calcein/cobalt quenching
method. DMSO (0.1% v/v) was used as vehicle control and ionomycin (IM; 2 µM) was used as positive control. Mitochondrial calcein fluorescence was
quantified. h Additional live measurement of the effect of PXA on mPTP opening in Ramos cells by the calcein/cobalt quenching method using flow
cytometry
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oligomycin A (complex V / ATP synthase). In an O2
consumption assay, PXA caused a strong decrease in
cellular respiration, both after CCCP treatment and under
basal conditions, similar to that caused by rotenone,
antimycin A and azide (Fig. 4b). Oligomycin A expectedly
inhibited respiration under basal conditions but not after
CCCP treatment since CCCP uncouples respiration from
ATP synthesis. TTFA did not have a significant effect,
probably because complex II is not involved in respiration
if complex I substrates are available19.
Since a functional ETC is required for ATP synthesis by
OXPHOS, we also compared PXA to known ETC inhi-
bitors in this context. Indeed, PXA as well as all tested
ETC inhibitors strongly reduced cellular ATP levels if
galactose was the only available sugar and ATP had to be
synthesised via OXPHOS instead of glycolysis (Fig. 4c).
Thus assuming that PXA targets the ETC, we tried to
determine if it specifically inhibits one of the ETC com-
plexes. This experiment was performed in permeabilized
cells, comparing PXA to rotenone. Succinate, which
induces complex II-dependent respiration only if complex
I is inhibited, alleviated rotenone-induced inhibition of O2
consumption but had only a marginal effect in PXA-
treated cells. In contrast, duroquinol, which induces
complex III-dependent respiration, increased O2 con-
sumption in both PXA-treated as well as rotenone-treated
cells back to levels before inhibition (Fig. 4d). These data
suggest that PXA might either affect both complex I and
II or the shuttling of electrons between complex I/II and
III.
Comparison of PXA with other ETC inhibitors
While PXA inhibits the ETC as well as ATP synthesis,
it differs from the other ETC inhibitors used in this study
concerning its effects on Ca2+ and ΔΨm. Unlike PXA,
neither CCCP nor any of the tested ETC inhibitors with
the exception of antimycin A caused a noticeable release
of Ca2+ (Fig. S4a), and that caused by antimycin A was
much weaker and had an earlier but slower onset than
the one caused by PXA. Similarly, while both CCCP and
PXA induced a strong and immediate decrease in ΔΨm,
none of the other ETC inhibitors except antimycin A had
any effect on ΔΨm, and that of antimycin A was much
slower and weaker (Fig. S4b). Since we previously
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showed that PXA is cytotoxic and induces apoptosis, we
also compared it to CCCP, ETC inhibitors, IM (control
for Ca2+ release) and staurosporine (control for cyto-
toxicity/apoptosis) in these regards. PXA, staurosporine
and CCCP strongly induced apoptosis, while the ETC
inhibitors and IM were much weaker inducers in Ramos
cells and did not noticeably induce apoptosis at all in
Jurkat cells (Fig. 5a, b). Dependency on OXPHOS for
ATP synthesis, which considerably increased the toxicity
of the ETC inhibitors, appeared to have no effect on the
toxicity of PXA or staurosporine (Fig. 5c, d). These
observations indicate that PXA probably causes cyto-
toxicity in general and apoptosis in particular not via its
effects on the ETC, ΔΨm, or [Ca2+]mito, but rather that
all of these events might have a common cause further
upstream.
PXA causes irreversible cleavage of OPA1 mediated by
OMA1 but not YME1L1
Several stress conditions including loss of ΔΨm and low
levels of ATP can induce cleavage of the IMM fusion
regulator OPA1 by the protease OMA1 (ref. 20). Addi-
tionally, OPA1 is also cleaved by the protease YME1L1,
resulting in fragments of different size. We treated MEF
cells deficient for either one or both of these proteases
with either PXA or CCCP. We observed that PXA, like
CCCP, caused stress-induced OPA1 cleavage that was
dependent on OMA1, whereas expression of YME1L1 did
not have any visible effect on PXA-induced OPA1 clea-
vage (Fig. 6a). Similarly to their effect in MEF cells, PXA
and CCCP-induced cleavage of OPA1 in Ramos and
Jurkat cells within minutes. Interestingly, and unlike
CCCP, removal of PXA did not enable recovery of the
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long OPA1 forms (Fig. 6b). This prompted us to also
investigate the effects of removal of PXA on cytotoxicity.
Indeed, though PXA was about fivefold less toxic if
removed after a few minutes, it still irreversibly primed
the cells for death (Fig. 6c). It, thus, appears that at least
some of the effects of PXA on the cells are irreversible.
PXA induces fragmentation of the inner but not of the
outer mitochondrial membrane independently of OMA1,
OPA1 and DRP1
Excessive processing of OPA1 by OMA1 changes
mitochondrial cristae morphology, resulting in the release
of pro-apoptotic factors such as CYCS and SMAC. We,
therefore, investigated the effects of PXA on SMAC
localisation and on recruitment of BAX to the OMM. We
observed that PXA indeed induced recruitment of GFP-
BAX to the mitochondria, with concurrent release of
SMAC-mCherry into the cytosol, within about 2–3 h
(Fig. 7a and Supplementary Movie S4; quantification
shown in Fig. S5). OPA1 processing by OMA1 also pre-
vents IMM fusion and, if excessive, results in mitochon-
drial fragmentation. Intriguingly, PXA caused rapid
fragmentation of the mitochondrial network within min-
utes (Fig. 7b), and independent of the cells’ OMA1 or
YME1L1 status (Fig. 7c, left panels; Supplementary
Movies S5–S7). The persistence of PXA-induced
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Cells were incubated in full growth medium containing either glucose or galactose as the only available sugar. Galactose alone forces the cells to
resort exclusively to OXPHOS for ATP synthesis. d Live measurement of mitochondrial respiration in Ramos cells permeabilized by digitonin (Digi; 5
µg/ml). The effect of PXA (first 1 µM, then increased to 10 µM as indicated) was compared to that of the known complex I inhibitor rotenone (Rot; 1
µM). To specifically induce complex II and III of the electron transport chain, succinate (Succ; 10 mM) and duroquinol (Duro; 1 mM) were used,
respectively. Measurement of extracellular [O2] was performed using an oxygraph
Böhler et al. Cell Death and Disease  (2018) 9:286 Page 7 of 17
Official journal of the Cell Death Differentiation Association
mitochondrial fragmentation in OMA1-YME1L1 DKO
cells indicates that this process is independent of OPA1
cleavage.
Mitochondrial fission is also regulated by the dynamin
DRP1, which mediates OMM fission. We, thus, tested the
effect of PXA on the mitochondrial morphology in DRP1-
deficient MEF cells. Again, fragmentation was observed
within minutes after treatment (Fig. 7c, right panel;
Supplementary Movie S8). We next used dual staining of
both the matrix (via HSP60) as well as the OMM (via
TOMM20) to determine whether both or only one of
these structures are affected by PXA. CCCP was used as a
positive control for fragmentation. As expected, CCCP
could not induce fragmentation in DRP1-KO cells, and in
WT cells it induced fragmentation of both the IMM and
OMM together (Fig. 8a, b). In contrast, in the WT cells
treated with PXA, fragmentation was much stronger and
resulted in smaller fragments. More intriguingly, in
DRP1-KO cells treated with PXA, only the matrix
appeared to have fragmented, whereas the OMM
appeared to have shrunken around the matrix fragments
but otherwise remained connected (Fig. 8a, b). This effect
could also be observed in cells deficient for both DRP1
and OPA1 (Fig. S6) demonstrating that PXA acts inde-
pendently of canonical regulators of mitochondrial fission.
Finally, a close examination of the mitochondrial ultra-
structure by transmission electron microscopy (TEM)
revealed that PXA causes OMA1-independent disruption
of mitochondrial matrix morphology, complete loss of
cristae, and condensation of IMM structures at the OMM
(Fig. 8c).
Taken together, our results show that PXA disturbs
mitochondrial form and function in several ways. Some
effects, such as the rapid inhibition of both ΔΨm and the
ETC at the same time, the delayed release of mitochon-
drial Ca2+, and the fragmentation of the inner but not the
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Fig. 5 Comparative measurements of the effect of PXA and other compounds on apoptosis induction and cytotoxicity in Jurkat and
Ramos cells. PXA (10 µM) was compared to the protonophore carbonyl cyanide m-chlorophenyl hydrazone (CCCP; 10 µM), the Ca2+ ionophore
ionomycin (IM; 10 µM), the apoptosis inducer staurosporine (STS; 10 µM), and the complex-specific ETC inhibitors rotenone (Rot; complex I; 10 µM),
antimycin A (AmA; complex III; 10 µM) and oligomycin A (OmA; complex V; 10 µM). Data shown are the means of three independent experiments;
error bars = SD. a, b Measurement of apoptosis induction based on cleavage of the pro-fluorescent CASP3 substrate Ac-DEVD-AMC, which results in
release of AMC (Ex 360 nm, Em 450 nm), as an indicator of apoptosis. c, d Measurement of cytotoxicity after 24 h of treatment in the presence of
either glucose or galactose as the only available sugar. Galactose alone forces the cells to resort exclusively to OXPHOS for ATP synthesis.
Measurement was performed in a microplate reader using the MTT viability assay
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outer mitochondrial membrane, are unique and indicate a
mode of action that is distinct from all other compounds
to which it was compared in this study.
Discussion
The mycotoxin PXA is a toxic natural product whose
mechanism of action has so far remained elusive. We
provide evidence that PXA disrupts mitochondrial func-
tion and causes IMM fragmentation and cristae disrup-
tion independently of DRP1 and OPA1, leading to the
release of pro-apoptotic factors and ultimately to
apoptosis.
PXA, just like CCCP, dissipates ΔΨm within seconds. In
the case of CCCP, respiration increases to compensate
this, whereas PXA has the opposite effect and blocks
respiration. Conversely, respiration is also blocked by
ETC inhibitors, yet in contrast to PXA, these do not
strongly affect ΔΨm. This suggests an entirely different
mode of action for PXA. Additionally, unlike any of these
compounds, PXA causes a strong mitochondrial release of
Ca2+ and rapid fragmentation of the IMM but not the
OMM.
Release of mitochondrial Ca2+ and loss of ΔΨm can be
results of persistent mPTP opening, yet we showed that
PXA does not strongly affect the mPTP. Since mito-
chondrial ion gradients are interdependent through var-
ious antiporters that are generally linked to ΔΨm (ref. 2),
one might assume that loss of ΔΨm disturbs these gra-
dients sufficiently to induce a net Ca2+ efflux from the
mitochondria. For CCCP, contradictory results have been
reported—in some cases it caused Ca2+ release21, in some
cases it did not22. We observed no effect of CCCP and
most ETC inhibitors on [Ca2+]cyt, and in fact both ETC-
deficient (ρ0) mitochondria23 and depolarised mitochon-
dria24 can still facilitate a net uptake of Ca2+. It, thus,
appears that the mitochondrial Ca2+ release induced by
PXA is not necessarily a result of its effects on the ETC
and ΔΨm, but rather that all of these effects might have a
common cause.
The delay between addition of PXA and the first
observable increase in [Ca2+]cyt and decrease in [Ca
2+]mito
contrasts with the immediate change in ΔΨm (Fig. 3d).
This discrepancy could possibly be explained by the
hypothesis that mitochondria release Ca2+mainly into the
cristae, and that the cristae junctions may function as
bottlenecks for mitochondrial Ca2+ transport8,25. Cristae
junctions are regulated by OPA1, which is cleaved by
OMA1 in response to mitochondrial stress, leading to
cristae disruption26. We not only showed that OPA1 is
irreversibly cleaved by OMA1 upon PXA treatment, but
that PXA also causes cristae disruption independently of
OMA1. Thus, PXA-induced cristae disruption might
cause the release of Ca2+ from the cristae and thus
eventually into the cytosol. In addition, irreversible cristae
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disruption could well be a sufficient condition for the
release of pro-apoptotic factors and thus the induction of
apoptosis26–28.
OPA1 also affects the fragmentation of mitochondrial
network structures, which can be induced by PXA as well
as CCCP. In the case of CCCP, this is commonly
explained by the excessive activation of DRP1 after
increased OPA1 processing by OMA1, which in turn is a
response to several kinds of cellular stress including
impaired ATP production and loss of ΔΨm (ref. 4,6,20,29–
32). Since PXA dissipates ΔΨm, inhibits ATP production
and consequently induces OMA1-mediated OPA1 clea-
vage, one might assume that it induces fragmentation via
the same mechanism, yet we observed PXA-induced
fragmentation events that were independent of DRP1,
OMA1 and even OPA1.
Mitochondrial fragmentation independent of DRP1 is
an unusual phenomenon but has been reported in cells
undergoing apoptosis after pro-apoptotic factors had
already been released33,34. In the case of PXA, however,
fragmentation occurs within minutes after treatment,
whereas pro-apoptotic factors are released only after
several hours. In addition, whereas both the OMM and
IMM are divided together during DRP1-dependent frag-
mentation, PXA can cause exclusive fragmentation of the
IMM while the OMM remains intact. This is surprising
since no active mechanism for exclusive IMM fission is
known in higher eukaryotes, and there are only few
reports documenting this phenomenon6,35,36.
The OMA1-processed short OPA1 forms play a role in
IMM fission and cristae morphology5,29,35. However, since
PXA-induced IMM fragmentation and cristae disruption
are independent of both OMA1 and OPA1, this implies
that OPA1 may well be an IMM fission regulator but not
necessarily a fission executor. It has been recently pro-
posed that OPA1 is dispensable for cristae junction bio-
genesis but may still be required for cristae junction
remodelling37. Our results suggest that excessive OPA1
processing may be sufficient but not necessary for inner
membrane remodelling and cristae disruption and for the
consequent release of pro-apoptotic factors.
The independence of PXA-induced IMM fragmentation
from DRP1, OMA1 and OPA1, as well as its very fast
onset, suggest that it might not depend on the fission/
fusion machinery at all, but could work via a completely
separate mechanism. Since no such mechanism is known
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in higher eukaryotes, any attempt at explaining this effect
remains speculative. One explanation could be a change
in IMM fluidity or matrix architecture, causing an
immediate and strong retraction of the IMM. This could
result from interference with the tethering of IMM and
OMM at mitochondrial contact sites. If this is the case, a
possible mechanistic target of PXA could be the mito-
chondrial phospholipid cardiolipin, which is present
almost exclusively in the IMM and especially at mito-
chondrial contact sites38,39. Cardiolipin serves as a
membrane anchor for many proteins that are implicated
in mitochondrial contact site formation, mitochondrial
ultrastructure and the ETC, such as MIC27 (APOOL)40,41,
F1FO ATP synthase
41,42, CYCS41, and ETC complexes III
and IV41,43,44. A disruptive interaction between PXA and
either cardiolipin or cardiolipin-binding proteins might
thus explain several of the effects induced by PXA.
In summary, we identified PXA as a mitochondrial toxin
with a mode of action distinct from known ETC inhibi-
tors, OXPHOS uncouplers, and ionophores. Its effects,
such as the rapid inhibition of both ETC and ΔΨm, the
release of mitochondrial Ca2+, and the induction of
DRP1- and OPA1-independent cristae disruption and
fission of the inner but not the outer mitochondrial
membrane, might render it a useful tool in studying these
phenomena. Further studies may reveal the molecular
target of PXA and the mechanisms through which it
induces mitochondrial Ca2+ release and IMM fission.
Material and methods
Cell lines and cell culture
Jurkat cells were obtained from DSMZ (#ACC-282).
Ramos cells were kindly provided by Michael Engelke
(Institute of Cellular and Molecular Immunology, Uni-
versity Hospital Göttingen, Göttingen, Germany). HeLa
cells stably expressing mito-DsRed were kindly provided
by Aviva M. Tolkovsky (Department of Clinical Neu-
rosciences, University of Cambridge, England, UK) and
have been described previously45. MEF cells deficient for
OMA1 and/or YME1L1 as well as the corresponding
wild-type cells were generated by Ruchika Anand and
kindly provided by Thomas Langer (Institute for Genetics,
University of Cologne, Germany) and have been described
previously29. MEF cells deficient for DRP1 as well as the
corresponding wild-type cells used for live imaging were
kindly provided by Hiromi Sesaki (Department of Cell
Biology, Johns Hopkins University, Baltimore, MD, USA)
and have been described previously33. MEF cells deficient
for DRP1 used for imaging of fixed cells were generated
using the CRISPR/Cas9 system as described previously46.
The DNA target sequence for the guide RNA was 5'-
CAGTGGGAAGAGCTCAGTGC-3'. HCT116 cells were
kindly provided by Frank Essmann (Interfaculty Institute
of Biochemistry, Eberhard Karls University Tübingen,
Germany). Transient expression of SMAC-mCherry and
GFP-BAX was achieved by lipofection at 70–80% con-
fluence using Lipofectamine 2000 (Life Technologies,
Darmstadt, Germany). Cells were incubated with 0.15 µl
Lipofectamine 2000, 50 ng pcDNA3-Smac(1-60)mCherry
(Addgene ID 40880; this plasmid was kindly provided by
Stephen Tait (Beatson Institute, University of Glasgow,
Scotland, UK) and has been described previously47), and
50 ng pGFP-Bax (kindly provided by Nathan R. Brady,
Department of Molecular Microbiology and Immunology,
Johns Hopkins University, Baltimore, MD, USA) per well
in glass bottom 8-well chambers (Ibidi, Planegg, Ger-
many) for 16 h. HeLa cells used for Ca2+ measurements
were cultured in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal calf serum (FCS) and 4mM
L-glutamine, 100 U/ml penicillin and 100 μg/ml strepto-
mycin at 37 °C and 5% CO2. They were authenticated
using autosomal STR profiling performed by the Uni-
versity of Arizona Genetics Core and they fully matched
the DNA fingerprint present in reference databases. Cell
lines stably expressing either mito-DsRed (except HeLa;
see above) or ratiometric mito-Pericam were generated by
retroviral transfection using the Platinum-E (Plat-E)
packaging cell line (kindly provided by Toshio Kitamura,
Institute of Medical Science, University of Tokyo, Japan)
and the retroviral vectors pMSCVpuro-mito-DsRed1
(Addgene ID 87379) or pMSCVpuro-mito-Pericam
(Addgene ID 87381). The medium used for the cultiva-
tion of Jurkat cells and Ramos cells was RPMI 1640
medium, and the medium used for cultivation of HCT116
cells was McCoy’s 5A medium. All other cells were cul-
tivated in high-glucose Dulbecco's Modified Eagle's
medium (DMEM). All media were supplemented with
10% FCS, 100 U/ml penicillin, and 100 µg/ml streptomy-
cin. All cell lines were maintained at 37 °C and 5% CO2 in
a humidity-saturated atmosphere.
Reagents
Phomoxanthone A was isolated and purified as descri-
bed previously16. We found that PXA becomes unstable if
dissolved in dimethyl sulfoxide (DMSO) and readily iso-
merises into the essentially non-toxic compound dicer-
androl C (data not shown), in a process similar to the one
previously described for the structurally related secalonic
acids48. However, PXA is barely soluble in EtOH and not
soluble in H2O. Therefore, PXA was prepared in small
lyophilised aliquots and only dissolved in DMSO imme-
diately before usage.
The tyrosine phosphatase inhibitor pervanadate (VO4
3
−) was freshly prepared by mixing 30 mM sodium
orthovanadate with 60mM H2O2 in phosphate-buffered
saline (PBS) and incubating at room temperature (RT) in
the dark for 10min; sodium orthovanadate was purchased
from Sigma (Munich, Germany), #450243; IM from
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Sigma, #I9657; thapsigargin (TG) from Sigma, #T9033;
carbonyl cyanide m-chlorophenyl hydrazone (CCCP)
from Sigma, #C2759; rotenone from Sigma, #45656; the-
noyltrifluoroacetone (TTFA) from Sigma, #88300; anti-
mycin A from Sigma, #A8674; sodium azide (NaN3) from
Sigma, #S2002; oligomycin A from Toronto Research
Chemicals (Toronto, Canada), #O532970; staurosporine
(STS) from LC Laboratories (Woburn, MA, USA), #9300.
All cell culture reagents were purchased from Life
Technologies, and all other reagents where no manu-
facturer is explicitly mentioned were purchased from Carl
Roth GmbH (Karlsruhe, Germany).
Replicates and statistical analysis
Experiments were replicated at least three times, and
representative data are shown. Error bars indicate stan-
dard deviation. All statistical analysis was performed using
Prism v7.01 (GraphPad Software, La Jolla, CA, USA).
In vitro kinase activity screening
The effect of PXA on the activity of 141 protein kinases
was assessed by the International Centre for Kinase Pro-
filing (Dundee, Scotland, UK) using a radioactive filter
binding assay with 33P ATP49,50.
Live measurement of [Ca2+]cyt by Fluo-4-AM
Cells were stained by incubation in growth medium
containing 1 µM Fluo-4-AM (Life Technologies;
#F14201), 0.005% w/v Pluronic F-127 (Sigma, #540025),
10 mM HEPES and 5% v/v FCS at 30 °C. After 25 min, an
equal volume of full growth medium was added, the
temperature was increased to 37 °C, and the cells were
incubated for another 10 min. After that, the cells were
washed and resuspended in Krebs-Ringer buffer (10 mM
HEPES pH 7.0, 140 mM NaCl, 4 mM KCl, 1 mM MgCl2,
10 mM glucose) supplemented with 1 mM CaCl2. The
cells were kept at RT in the dark until measurement. Just
before measurement, the cells were washed and resus-
pended in Krebs-Ringer buffer supplemented with 0.5
mM EGTA. Fluo-4-AM fluorescence was measured live
using an LSRFortessa flow cytometer (BD, Franklin
Lakes, NJ, USA) recording fluorescence in the FITC
channel (Ex 488 nm, Em 530 ± 30 nm). For each sample,
after at least 30 s of baseline measurement, the stimulus
was added and measurement was continued for at least
10 min.
Live measurement of [Ca2+]mito and [Ca
2+]ER by CEPIA
Measurements of [Ca2+]mito and [Ca
2+]ER in HeLa
single cells were performed as described previously51,52,
using the genetically-encoded Ca2+ indicators CEPIA3mt
(Addgene ID 58219) and G-CEPIA1er (Addgene ID
58215), respectively, which were developed by Dr. M. Iino
(The University of Tokyo, Japan)53. The constructs were
introduced into HeLa cells utilising the X-tremeGENE HP
DNA transfection reagent (Roche, Mannheim, Germany)
according to the manufacturer’s protocol. The [Ca2+]
measurements were performed 48 h after transfection
using a Zeiss Axio Observer Z1 Inverted Microscope
equipped with a 20× air objective and a high-speed
digital camera (Axiocam Hsm, Zeiss, Jena, Germany).
Changes in fluorescence were monitored in the GFP
channel (Ex 480 nm, Em 520 nm). Extracellular Ca2+ was
chelated with 3 mM EGTA, and PXA (10 μM) or thapsi-
gargin (1 μM) were added as indicated on the figures. All
traces were normalised (F/F0) where F0 is the starting
fluorescence of each trace.
Live measurement of [Ca2+]mito by ratiometric mito-
Pericam
Ramos cells stably transfected with ratiometric mito-
Pericam as described above were used for this measure-
ment. Ratiometric mito-Pericam is a Ca2+-sensitive
fluorescent protein and was described previously54,55. An
increase in [Ca2+] causes a shift of the Pericam excitation
maximum from ~410 to ~495 nm while the emission peak
remains at ~515 nm. Pericam fluorescence was measured
live using an LSRFortessa flow cytometer recording
fluorescence in both the FITC channel (Ex 488 nm, Em
530± 30 nm) and the AmCyan channel (Ex 405 nm, Em
525± 50 nm). For each sample, after at least 30 s of
baseline measurement, the stimulus was added and
measurement was continued for at least 10 min. The ratio
of fluorescence with excitation at 488 to 405 nm was
calculated.
Live measurement of mPTP opening by cobalt-calcein
assay
This method was adapted from previously published
protocols10,18,56. The cells were stained by incubation in
Krebs-Ringer buffer supplemented with 1 mM CaCl2, 1
mM CoCl2, and 1 µM calcein-AM (Life Technologies,
#65-0853-78) at 37 °C for 30min. After that, the cells were
washed and maintained in Krebs-Ringer buffer supple-
mented with 1 mM CaCl2 and 1.6 µM cyclosporin H
(CsH) to prevent passive efflux of calcein. For live mea-
surement by confocal microscopy, imaging and quantifi-
cation were performed using a Perkin Elmer Spinning
Disc microscope with a 60× objective (oil-immersion and
NA= 1.49) at an excitation wavelength of 488 nm. The
videos were obtained at 1000× 1000 pixel resolution with
a Hamamatsu C9100 camera. Additional live measure-
ment by flow cytometry was performed using an
LSRFortessa flow cytometer recording fluorescence in the
FITC channel (Ex 488 nm, Em 530± 30 nm). For each
sample, after at least 30 s of baseline measurement, the
stimulus was added and measurement was continued for
at least 10 min.
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Isolation of live mitochondria
Adherent cells were harvested by a cell scraper. All cells
were pelletised by centrifugation at 600 rcf, resuspended
in ice-cold mitochondria isolation buffer (210 mM man-
nitol, 70 mM sucrose, 1 mM K2EDTA, 20mM HEPES),
and passed through a 23 G needle ten times. The resulting
suspension was centrifuged at 600 rcf and the supernatant
was transferred to a new tube and centrifuged at 6500 rcf
and 4 °C for 15min. The resulting mitochondrial pellet
was resuspended in sodium-free mitochondrial respira-
tion buffer MiR05 (0.5 mM EGTA, 3 mM MgCl2, 60 mM
lactobionic acid, 20 mM taurine, 10 mM KH2PO4, 20 mM
HEPES, 110mM D-sucrose, 0.1% w/v fatty-acid-free
bovine serum albumin [BSA]) supplemented with 10
mM succinate and 5mM malate.
Live measurement of mitochondrial Ca2+ retention
capacity by calcium green
Live mitochondria isolated as described above were stained
by incubation in MiR05 buffer supplemented with 10mM
succinate, 5mM malate, and 1 µM calcium green AM (Life
Technologies, #C3012) for 20min on a shaker at 37 °C. Before
measurement, the mitochondria were pelletised at 6500 rcf
for 5min, washed and resuspended in MiR05 supplemented
with 10mM succinate, 5mMmalate, and 5 µM of either CsH
or CsA. In experiments where the mitochondria were loaded
with Ca2+ before measurement, this was achieved by incu-
bation in MiR05 additionally supplemented with 150 µM
CaCl2 on a shaker at 37 °C for 10min after the first washing
step and followed by a second washing step.
Measurement of mitochondrial membrane potential by
TMRE and TMRM
For measurement in whole cells, the cells were stained
by incubation in full growth medium containing 100 nM
tetramethylrhodamine ethyl ester (TMRE; AAT Bioquest,
Sunnyvale, CA, USA; #22220) and 10mM HEPES at 37 °C
in the dark for 15min. After that, the cells were washed
and resuspended in full growth medium containing 10
mM HEPES and were incubated at 37 °C in the dark for
another 15min. The cells were maintained at these con-
ditions until measurement. For measurement in live
mitochondria, these were isolated as described above,
resuspended in sodium-free mitochondrial respiration
buffer MiR05 supplemented with 10mM succinate, 5 mM
malat, and 1mM ADP, stained with 50 nM tetra-
methylrhodamine methyl ester (TMRM; Life Technolo-
gies, #T668) at 37 °C for 15min, and washed and
resuspended in MiR05 additionally supplemented with
1.6 µM cyclosporin H (CsH) to prevent passive TMRM
leakage. For live measurement, TMRE or TMRM fluor-
escence was measured using an LSRFortessa flow cyt-
ometer recording fluorescence in the PE channel (Ex 488
nm, Em 575± 26 nm). For each sample, after at least 30 s
of baseline measurement, the stimulus was added and
measurement was continued for at least 10 min. For the
titration of the EC50 for mitochondrial depolarisation,
TMRE fluorescence was measured using a Synergy Mx
microplate reader (BioTek, Bad Friedrichshall, Germany)
recording fluorescence at Ex 549± 9 nm, Em 575± 9 nm.
TMRE fluorescence was measured right before and 10
min after addition of PXA. EC50 values were calculated
using Prism v7.01.
Live O2 respirometry measurements
This method was adapted from previously published
protocols19,57. All measurements were performed using
an OROBOROS Oxygraph-2k (Oroboros Instruments,
Innsbruck, Austria). For measurement of total cellular
respiration, intact cells (2× 106 cells/ml) were used and
maintained in full growth medium supplemented with 20
mM HEPES during measurement. For direct measure-
ment of mitochondrial respiration, digitonin-
permeabilised cells (2× 106 cells/ml) were used and
maintained in mitochondrial respiration buffer MiR05
during measurement. To induce respiration, 10 mM glu-
tamate, 5 mM malate, 1 mM ADP, and 5 µg/ml digitonin
were added. The following complex-specific ETC indu-
cers were used: For complex II, 10 mM succinate (from
Sigma, #S3674); for complex III, 1 mM tetra-
methylhydroquinone / duroquinol (from TCI Germany,
Eschborn, Germany; #T0822); for complex IV, 50 µM
tetramethyl-p-phenylenediamine (TMPD; from Sigma,
#87890) supplemented with 200 µM ascorbate.
Fluorimetric O2 consumption assay
This measurement was performed using the MITO-ID®
Extracellular O2 Sensor Kit (High Sensitivity) (Enzo Life
Sciences, Lörrach, Germany; #51045) according to man-
ufacturer’s instructions. Fluorescence was measured using
a Synergy Mx microplate reader (Ex 340–400 nm, Em
630–680 nm; time-resolved fluorescence, delay time 30 µs,
integration time 100 µs).
Measurement of cellular ATP levels
This measurement was performed using the Mito-
chondrial ToxGlo™ Assay (Promega, Mannheim, Ger-
many; #G8000) according to manufacturer’s instructions.
Since most cancer cells prefer ATP synthesis by glycolysis
over OXPHOS if glucose is present, this experiment was
conducted in the presence of either glucose or galactose
as the only available sugar, the latter of which reduces the
net ATP yield of glycolysis to zero and forces the cells to
resort to OXPHOS for ATP production58,59.
Fluorimetric caspase-3 activity assay
Caspase-3 activity was measured as described pre-
viously60. Briefly, cells were harvested by centrifugation at
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600 rcf and lysed with 50 μl of ice-cold lysis buffer (20 mM
HEPES, 84 mM KCl, 10 mM, MgCl2, 200 μM EDTA, 200
μM EGTA, 0.5% NP-40, 1 µg/ml leupeptin, 1 μg/ml pep-
statin, 5 μg/ml aprotinin) on ice for 10min. Cell lysates
were transferred to a black flat-bottom microplate and
mixed with 150 μl of ice-cold reaction buffer (50 mM
HEPES, 100mM NaCl, 10% sucrose, 0.1% CHAPS, 2 mM
CaCl2, 13.35 mM DTT, 70 μM Ac-DEVD-AMC). The
kinetics of AMC release were monitored by measuring
AMC fluorescence intensity (Ex 360 nm, Em 450 nm) at
37 °C in intervals of 2 min over a time course of 150min,
using a Synergy Mx microplate reader. The slope of the
linear range of the fluorescence curves (Δrfu/min) was
considered as corresponding to caspase-3 activity.
Measurement of cell viability by MTT assay
Cell viability was determined by the ability to convert
the yellow MTT substrate (Roth, #4022) into a blue for-
mazan product. MTT solution (5 mg/ml MTT in PBS)
was added to cells to a final concentration of 1 mg/ml, and
the cells were then incubated at 37 °C for 60min and
pelletised at 600 rcf. The supernatant was discarded and
replaced with DMSO. After the formazan crystals were
fully dissolved, absorption was measured (test wavelength
570 nm, reference wavelength 650 nm). Reference absor-
bance was subtracted from test absorbance. Cell-free
medium samples were considered as having 0% viability
and the average of the control samples was considered as
having 100% viability. IC50 values were calculated using
Prism v7.01.
Immunoblotting
Cells were harvested by centrifugation at 11,000 rcf in 4
°C for 10 s, quick-frozen in liquid nitrogen, thawed on ice,
incubated in lysis buffer (20 mM Tris-HCl, 150mM NaCl,
1% v/v Triton X-100, 0.5 mM EDTA, 1 mM Na3VO4, 10
mM NaF, 2.5 mM Na4P2O7, 0.5% sodium deoxycholate,
protease inhibitor (Sigma, #P2714)) for 30 min and vor-
texed repeatedly. The cell lysates were then cleared from
cell debris by centrifugation at 20,000 rcf for 15 min.
Sodium dodecyl sulfate-polyacrylamide gel electrophor-
esis and western blot were performed according to stan-
dard protocol. The antibodies used for protein detection
were mouse anti-phospho-tyrosine (Merck-Millipore,
Darmstadt, Germany; clone 4G10, #05-1050); rabbit anti-
OPA1 (described previously37); mouse anti-ACTB (Sigma;
clone AC-74, #A5316); and mouse anti-VCL (Sigma;
clone hVIN-1, #V9131).
Confocal microscopy
Live imaging of HCT116 cells transiently expressing
GFP-BAX and SMAC-mCherry was performed using a
Zeiss LSM 710 ConfoCor3 microscope (Carl Zeiss, Jena,
Germany) with a C‐Apochromat× 40 N.A. 1.2 water
immersion objective (Zeiss). Excitation light came from
argon ion (488 nm) and DPSS (561 nm) lasers. The cells
were maintained in full growth medium at 37 °C and 5%
CO2 during imaging. Images were recorded every 5 min
and were processed with Fiji61. For each time frame, the
standard deviation (SD) of the fluorescence intensity was
measured for each channel. A low SD was considered as
corresponding to homogenous distribution, whereas a
high SD was considered as corresponding to
accumulation.
Live imaging of HeLa cells stably expressing mito-
DsRed was performed using a Cell Observer SD Dual
Cam spinning disc confocal microscope (Zeiss) equipped
with a C-Apochromat 63×, N.A. of 1.45 oil-immersion
objective. Excitation light came from an argon ion (488
nm) and DPSS (561 nm) laser. The cells were maintained
in full growth medium supplemented with 10mM HEPES
at 37 °C during imaging. Images were recorded every 5 s.
Live imaging of MEF cells stably expressing mito-DsRed
was performed using a Perkin Elmer Spinning Disc
microscope with a 60× objective (oil-immersion and NA
= 1.49) at an excitation wavelength of 561 nm. The videos
were obtained at 1000× 1000 pixel resolution with a
Hamamatsu C9100 camera. The cells were maintained in
full growth medium supplemented with 10mM HEPES at
37 °C during imaging.
For imaging of fixed HeLa and MEF cells, the cells were
seeded on glass coverslips and grown to 60–90% con-
fluence prior to experiments. Cells were treated with
either 10 μM PXA, 10 μM CCCP or 0.1% v/v DMSO for
30min, and were fixed by incubation with pre-warmed 4%
paraformaldehyde in PBS at 37 °C for 10min. Coverslips
were then washed once with PBS, followed by incubation
with PBS supplemented with 0.5% Triton X-100 for 10
min at RT. The coverslips were washed three times for
3–5min with PBS supplemented with 0.2% Tween-20
(PBS-T). The coverslips were then incubated at RT for 30
min with blocking buffer (PBS-T supplemented with 0.2%
fish gelatin and 5% goat serum) in a humidified box, fol-
lowed by 1 h incubation with primary antibodies (anti-
HSP60 clone N-20, #sc-1052 and anti-TOMM20 clone
FL-145, #sc-11415 both from Santa Cruz, Dallas, TX,
USA) diluted in blocking buffer. The coverslips were then
washed three times with PBS-T, and incubated with
blocking buffer for 30min before adding secondary anti-
bodies (Alexa Fluor 488-labelled donkey anti-goat and
Alexa Fluor 594-labelled donkey anti-rabbit). Immuno-
fluorescence images were acquired with a Marianas
spinning disc confocal microscope (Intelligent Imaging
Innovations, Denver, CO, USA).
Transmission electron microscopy
TEM samples were fixed for a minimum of 4 h in 2.5%
v/v glutaraldehyde (GA) and 4% w/v paraformaldehyde
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(PFA) in 0.1M cacodylate buffer (pH 7.4) at 4 °C. Then,
samples were incubated in 1% osmium tetroxide in 0.1M
cacodylate buffer for 2 h. Dehydration was achieved using
acetone (50%, 70%, 90% and 100%) and block contrast was
applied (1% phosphotungstic acid/0.5% uranylacetate in
70% acetone). A SPURR embedding kit (Serva, Heidel-
berg, Germany) was used to embed samples, which were
polymerised overnight at 70 °C, before cutting into 80 nm
sections using an Ultracut EM UC7 (Leica, Wetzlar,
Germany). Images were captured using an H600 TEM
(Hitachi, Tokyo, Japan) at 75 kV.
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